TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/13/22 11:46 | 12/9/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | CA | O | VP,COO | P | 10 | 0.6105 | 0 | 16 | 0 | I | |||||||||||||||
11/23/22 16:29 | 11/21/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | CA | O | VP,COO | P.m | 2 | 0.5600 | 0 | 4 | 3 | 141 | I | ||||||||||||||
11/21/22 14:49 | 11/17/22 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | CA | O | VP,COO | P.m | 12 | 0.5577 | 0 | 21 | 18 | 137 | I | ||||||||||||||
4/26/21 16:33 | 4/22/21 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | NY | OT | Secretar | M | 15 | 0.9000 | 0 | 17 | 76 | 39 | D | ||||||||||||||
2/19/16 16:36 | 2/17/16 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | NY | T | P.m | 16 | 0.2984 | 0 | 54 | 115 | 100 | D | |||||||||||||||
2/4/16 20:14 | 2/4/16 | LIXT | Lixte Biotechnology Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Forman Eric | NY | T | P | 1 | 0.2500 | 0 | 3 | 6 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |